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IndustrialAbstract Traditional medical practitioners in Hawaii and Polynesia have used Morinda citrifolia
L. (Noni) for centuries to cure or prevent varieties of illnesses. The popularity of M. citrifolia as
a dietary supplement, a food functional ingredient, or as a natural health enhancer is increasing
throughout the world. M. citrifolia contains phytochemicals that own antibacterial, antiviral, anti-
fungal, antitumor, anthelminthic, analgesic, hypotensive, anti-inﬂammatory and immune enhancing
effects. Moreover, the increasing vogue ofM. citrifolia has attracted industries to employ it as a part
of various products and for wide applications such as a natural source of medicines and chemical
reagents as well as a green insecticidal. The wide spread of M. citrifolia in tropical climate of the
globe, from USA to Brazil reaching to Tahiti, Malaysia and Australia, contributed in enriching
its uses and potentials due to the variation in harvest locations. M. citrifolia parts including fruits,
seeds, barks, leaves, and ﬂowers are utilized on their own for individual nutritional and therapeu-
tical values, however, the fruit is considered to contain the most valuable chemical compounds. This
review discusses in details the industrial uses and the pharmacological activities ofM. citrifolia fruit,
seed, leaf and root, along with their isolated phytochemical compounds, through describing the
conducted in vitro and in vivo studies as well as clinical data.
ª 2015 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).clinical
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Morinda citrifolia is the scientiﬁc name of the commercially
known plant Noni. The name Morinda citrifolia is also refer-
ring to the botanical name which is originally derived from
the two Latin words ‘‘morus’’ imputing to mulberry, and
‘‘indicus’’ imputing to Indian, it belongs to the Rubiaceae fam-
ily (Nelson, 2006). In HawaiiM. citrifolia called Noni, whereas
in India it is called Indian mulberry and nuna, or ach.
Malaysians call it mengkudu and in Southeast Asia it is called
nhaut, while in the Caribbean, it is called the painkiller bush or
cheese fruit (Chan-Blanco et al., 2006).
Currently, there are two recognized varieties ofM. citrifolia
(M. citrifolia var. citrifolia andM. citrifolia var. bracteata) and
one cultivar (M. citrifolia cultivar Potteri). The most com-
monly found variety is M. citrifolia var. citrifolia, with the
greatest health and economic importance. Traditional healers
can recognize these varieties by the leaf size and shape, in addi-
tion to the fruit odor; however, most research has not distin-
guished between the different M. citrifolia varieties yet
(Pawlus and Kinghorn, 2007).Please cite this article in press as: Abou Assi, R. et al.,Morinda citrifolia (Noni): A co
trialsMorinda citrifolia (Noni): A comprehensive review –>. Arabian Journal of ChIn the early 1990s, the ﬁrst commercialized products
derived from M. citrifolia fruit in USA were lunched
(Santhosh Aruna et al., 2013). Later, in 1996,M. citrifolia juice
was introduced as a wellness drink, due to numerous reports
stating its therapeutic effects (Kamiya et al., 2009). In 2003,
the fruit juice of M. citrifolia was approved as a novel food
by the European commission; however, this approval was lim-
ited to the Tahitian fruit juice and not to other products
(Potterat and Hamburger, 2007). Amazingly, even with the
absence of speciﬁc mechanisms of action for the claimed M.
citrifolia effects (Kamiya et al., 2009), yet the market annual
sales of M. citrifolia products claimed to reach up to US $
1.3 billion (Potterat and Hamburger, 2007).
2. Chemical constituents
Almost 200 phytochemicals were identiﬁed and isolated from
different parts of M. citrifolia (Singh, 2012), however, up to
date, the complete phytochemical composition of the M. citri-
folia has not been fully reported. The chemical compositions
and their concentrations are related signiﬁcantly not only tomprehensive review on its industrial uses, pharmacological activities, and clinical
emistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.06.018
Figure 1 The most studied harvest locations and brands of M. citrifolia all over the world based on our review.
Morinda citrifolia (Noni): A comprehensive review 3the part of the plant but also to its country of origin (Deng
et al., 2010), and to the harvesting season (Iloki Assanga
et al., 2013), however, the optimization of agricultural/post-
harvest practices or processing technologies have been
neglected (Chan-Blanco et al., 2006). Fig. 1 illustrates the most
studied harvesting locations and brands of the M. citrifolia
around the world.
Under favorable conditions, the plant can bear fruit about
nine months to one year after planting, where M. citrifolia
plots are usually harvested two or three times per month and
one hectare of M. citrifolia can yield around 35 tons of juice.
Fruits are usually harvested at different stages, but most pro-
cessors buy them at the ‘‘hard white’’ stage for juice produc-
tion (Chan-Blanco et al., 2006). The evolution of fruits
phytochemical constituents, as well as isolation and identiﬁca-
tion of the bioactive compounds with their activity upon the
different stages is not fully addressed yet. In one study,
Mexican M. citrifolia fruit was assessed during its different
maturity stages (1–4) for its phytochemical constituents, ﬁnd-
ing that it has high levels of soluble protein, carbohydrates,
ascorbic acid, rutin and phenols, with an independent proﬁle
of season (Lewis Luja´n et al., 2014). It was suggested that
the exposure of the fruits to light or high temperatures imme-
diately after harvest does not affect their overall quality (Chan-
Blanco et al., 2006), yet, precise studies are required to specify
under which temperature and light conditions fruit quality
remains stable.
According to a Malaysian medicinal plants book,
M. citrifolia chemical constituents are: 5,7-Acacetin-7-O-b-
D(+)-glycopyranoside, ajmalicine isomers, alizarin,
asperuloside, asperulosidic acid, chrysophanol (1,8-dihy
droxy-3-methylanthraquinone), damnacanthol, digoxin, 5,6-
dihydroxylucidin, 5,6-dihydroxylucidin-3-b-primeveroside,
5,7-dimethylapigenin- 40-O-b-D(+)-galacto pyranoside, luci-
din, lucidin-3-b-primeveroside, 2-methyl-3,5,6-trihydroxy
anthraquinone, 3-hydroxymorindone, 3-hydroxymorindone-6
-b-primereroside, a-methoxyalizarin, 2-methyl-3,5,6-trihydrox
yanthraquinone-6-b-primeveroside, mono-ethoxyrubiadin,
morindadiol, morindin, morindone (1,5,6-trihydroxy-2-
methylanthraquinone), morindone-6-b-primeveroside, nor-
damnacanthal, quinoline, rubiadin, rubiadin 1-methyl ether,
saronjidiol, ursolic acid, alkaloids, anthraquinones and their
glycosides, caproic acid, caprylic acid, fatty acids and alcohols
(C5-9), ﬂavones glycosides, ﬂavonoids, glucose (b-D-
glucopyranose), indoles, purines, and b-sitosterol (Krishnaiah
et al., 2012).
Till now, 51 volatile compounds were identiﬁed in the M.
citrifolia ripe fruit, without clear speciﬁcation of the fruitPlease cite this article in press as: Abou Assi, R. et al.,Morinda citrifolia (Noni): A co
trialsMorinda citrifolia (Noni): A comprehensive review –>. Arabian Journal of Chharvest locations and stage conditions. These compounds
include organic acids such as octanoic and hexanoic acids,
alcohols including 3-methyl-3-butene-1-ol, and esters like
methyl octanoate, and methyl decanoate, as well as ketones
as 2-heptanone, and lactones (E)-6-dodeceno--lactone (Farine
et al., 1996).
The lyophilized Tahitian M. citrifolia fruit juice contains
trace elements including manganese (6.11 ± 0.21 g L1), cop-
per (2.22 ± 0.31 g L1), molybdenum (0.160 ± 0.004 g L1),
and cobalt (0.0474 ± 0.0006 g L1) (Rybak and Ruzik,
2013). Minerals including potassium, sulfur, calcium, phos-
phorus and traces of selenium were reported in the fruit juice
of M. citrifolia from Cambodia (Chunhieng, 2003), while vita-
mins such as ascorbic acid and pro-vitamin A were detected in
the Indian and Micronesian M. citrifolia fruit (Krishnaiah
et al., 2012; Shovic and Whistler, 2001). Thai concentrated
M. citrifolia fruit juice total fatty acid content reported to be
149 ± 8.735 mg/100 g, and its amino acids content was as fol-
lows: glutamate, alanine, arginine (range 20–26 mg/100 g); gly-
cine, cysteine, methionine, tyrosine, phenylalanine, lysine
(range 9.0–14.5 mg/100 g) and threonine, serine, valine, isoleu-
cine, leucine (range 3–6.5 mg/100 g). The highest and lowest
content was aspartate 34.9 (mg/100 g) and histidine
(2.0 mg/100 g), respectively (Rawangban et al., 2011).
Phenolic compounds are also dominating in the fruit of M.
citrifolia, including damnacanthal, scopoletin, morindone, ali-
zarin, aucubin, nordamnacanthal, rubiadin, rubiadin-1-methyl
ether, and anthraquinone glycosides (Mahanthesh et al., 2013).
A phytochemical screening for the presence of secondary
metabolite was conducted on the Indian M. citrifolia fruit
aqueous, ethanol and methanol extracts detecting steroids, car-
diac glycosides, phenol, tannins, terpenoids, alkaloids, carbo-
hydrates, ﬂavonoids, reducing sugar, lipids and fats in all
types of extracts, while saponins in aqueous and methanol
extracts, as well as acidic compounds in aqueous extract only
(Nagalingam et al., 2012), Brazilian M. citrifolia fresh fruit
pulp showed the presence of reducing sugars mainly glucose,
fructose and sucrose, and suggested large amount of minerals
(Da Silva et al., 2012). Recently, phytochemical screenings of
different commercial Nigerian M. citrifolia juice extracts con-
ﬁrmed the presence of secondary metabolites such as reducing
sugars, phenols, tannins, ﬂavonoids, saponins, glycosides, ster-
oids, terpenoids, alkaloids, and acidic components, and the
study also reported the absence of anthraquinones, phylo-
batannins and resins (Anugweje, 2015). Brazilian aqueous
extracts from M. citrifolia leaves phytochemical screening
showed the presence of alkaloids, coumarins, ﬂavonoids, tan-
nins, saponins, steroids, and triterpenoids (Seraﬁni et al.,mprehensive review on its industrial uses, pharmacological activities, and clinical
emistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.06.018
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roots dichloromethane extract have resulted in the
isolation and characterization of ten anthraquinone
including: I-hydroxy-2methylanthraquinone, nordamnacan-
thal, damnacanthal, morindone, rubiadin-I-methyl ether,
soranjidiol, rubiadin and damnacanthol (Saidan, 2009).
Furthermore screening led to the identiﬁcation of twenty com-
pounds from the Chinese dried M. citrifolia seeds ethanol
extract including daucosterol, ursolic acid, 19-hydroxyl-
ursolic acid, 1,5,15-trimethylmorindol, 5,15-dimethyl-
morindol, scopoletin, 3,30-bisdemethylpinoresinol, 3,4,3040-tet
rahydroxy-9,70a-epoxylignano-7a,90-lactone, americanin D,
americanin A, americanin, isoprincepin, deacetyl- asperulo-
sidic acid, loganic acid, asperulosidic acid, rhodolatouside,
quercetin-3-O-a-L-rhamnopyranosyl-(1ﬁ6)-b-D-glucopyra-
noside, 4-ethyl-2-hydroxyl-succinate, 5-hydroxymethyl-2-fur
ancarboxaldehyde, 3-methylbut-3-enyl-6-O-b-D-glucopyra-
nosyl-b-D-glucopyranoside (Yang et al., 2009). For a novel
and accurate outcomes, M. citrifolia studies quality can be
improved through developing identiﬁcation markers for its
chemical components and characterize their chemical struc-
tures on TLC, HPTLC, HPLC, NMR spectroscopy
(Saminathan et al., 2014). Table 1 summarizes the major
chemical components ofM. citrifolia different organs and their
phytochemical classiﬁcation and proven activities.3. Industrial uses
M. citrifolia is involved in various green industrial sectors,
including the following:
3.1. Natural preservative
M. citrifolia is recognized as a novel food ingredient under the
name of Noni fruit puree (Efsa, 2009), however, food industry
is mainly interested in TahitianM. citrifolia due to its leaf, fruit
and root antioxidant properties which are similar to vitamin E,
and they also contain butylated hydroxytoluene (a phenol
derivative) which has a natural preservative activity (Zin
et al., 2002), and was effective in blocking warmed-over ﬂavor
in formerly stewed beef pies, by reducing lipid oxidation, as
well as enhancing color stability and the shelf life of the ﬁnal
aerobically wrapped pies (Nathan et al., 2012). Despite of
the proven in vivo safety of Tahitian M. citrifolia as a food
ingredient (West et al., 2011), yet, the unpleasant off-taste of
its puree might restrict its use as a preservative (Nathan
et al., 2012). Interestingly, the addition of maltodextrin to
the M. citrifolia pulp powder (Fabra et al., 2011), as well as
to the spray dried seedless M. citrifolia fruit powder, success-
fully eliminated M. citrifolia bad smell and unpleasant taste,
and increased its resistance to humidity (Anwar and Arsyadi,
2007), yet no study has observed the effect of maltodextrin
complexation with M. citrifolia on enhancing its preservative
effects with less or no distasteful ﬂavor and odor.
3.2. M. citrifolia juice
The M. citrifolia juice products are a corner stone within its
industrial sector. Fresh Noni juice is obtained by compressingPlease cite this article in press as: Abou Assi, R. et al.,Morinda citrifolia (Noni): A co
trialsMorinda citrifolia (Noni): A comprehensive review –>. Arabian Journal of Chthe fruits immediately after harvesting (Newton, 2002),
whereas homemade juice is prepared by letting the fruits
decompose naturally (Brown, 2012), and commercial juice is
made by fruit fermentation (Nelson, 2006). The chemical com-
position of M. citrifolia juice depends majorly upon the
method of juice extraction. The physiochemical screening of
the fermented IndianM. citrifolia fruit showed that it contains
anthraquinones, saponins, and scopoletin (Satwadhar et al.,
2011), while the bioactive screening of the Thai M. citrifolia
fermented fruit juice recorded a superior vitamins content
(C, B1, B2, B3, B12) in comparison to the vitamin content
of the AmericanM. citrifolia fruit, it was also containing alka-
loids, anthraquinones, antioxidants, essential oils, ﬂavonoids,
saponins, scopoletin and sugars, and these results were congru-
ent to the content of the commercial Thai fruit juice content
(Nandhasri et al., 2005). To overcome problems associated
with transport and storage,M. citrifolia juice was concentrated
(Valde´s et al., 2009). However, its processing methods and
storage conditions inﬂuence juice stability. For example, heat
affects the organoleptic nature of the concentratedM. citrifolia
juice (Valde´s et al., 2009), while a fermentation process for
90 days caused about 90% reduction of its radical-
scavenging activity (RSA), and a dryness at 50 C reduced
the RSA by 20%, as for freshly prepared M. citrifolia juice,
the RSA is decreased by more than 90% if it is stored at
24 C for 90 days, whereas the RSA of the juice or powder is
reduced by 10–55% when stored for 90 days at 18 C and
4 C, respectively (Yang et al., 2007). M. citrifolia beverages
taste was enhanced in an economic juice recipe which was pre-
pared by mixing 10% of fermented juice extract of an Indian
M. citrifolia ripe fruit with 14% total suspended solids
(T.S.S.) and 2% ginger extract (Joshi et al., 2012). Only one
published research has studied the stability ofM. citrifolia ﬁnal
products where the concentrated Thai fruit juices and its dried
powders showed stability for 451 days (Rawangban et al.,
2011). This is indicating that stability factor should be consid-
ered more in future studies.
Many of M. citrifolia commercial juice parameters should
be ﬁxed including its concentrations variations, the prevalent
bioactive component in the fermented products, pasteurization
impact on these bioactive compounds, and the speciﬁcation
regarding the juice source for being fermented, and for how
long, and pasteurized or unpasteurized (Brown, 2012).
3.3. M. citrifolia probiotic juice
Seedless fermented M. citrifolia fruit juice from Taiwan
showed potentials for the production of probiotic which was
produced by reacting M. citrifolia juice (as a raw substrate)
with lactic acid bacteria (Lactobacillus casei and
Lactobacillus plantarum) or Biﬁdo-bacteria (Biﬁdobacterium
longum). After 48 h. of fermentation, all tested strains grew
well on M. citrifolia juice and colony-forming reached nearly
109 units/ml. Lactobacillus casei produced less lactic acid than
Biﬁdobacterium longum, whereas Lactobacillus plantarum,
Biﬁdobacterium longum and Lactobacillus plantarum survived
under low-pH conditions in a cold storage at 4 C for a period
of 4 weeks. The results indicated that Biﬁdobacterium longum
and Lactobacillus plantarum bacteria are selective for produc-
ing a probiotic M. citrifolia juice (Wang et al., 2009a).mprehensive review on its industrial uses, pharmacological activities, and clinical
emistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.06.018
Table 1 A list of identiﬁed compounds and their activities in fruit, leaf and root of M. citrifolia.
Plant part Compound Chemical
classiﬁcation
Activities/uses Reference
Leaf Americanin A Lignan Larvicidal, antioxidant Kovendan et al. (2012) and Kovendana
et al. (2014)
Proline Amino acid A source of essential and
conditional amino acids
Shovic and Whistler (2001), Elkins (1998)
and Sang et al. (2001)Leucine
Cysteine
Methionine
Glycine
Histidine
Isolucine
Glutamic acid
Phenylalanine
Serine
Threonine
Tryptophan
Tyrosine
Arginine
Valine
Quercetin-3-O-b-D-
glucopyranoside
Flavonoids Antimicrobial Chan-Blanco et al. (2006) and Sang et al.
(2001)
Quercetin-3-O-a-L-
rhamnopyranosyl-(1-6)-b-D-
glucopyranoside
Ursolic acid Triterpenoids Anticancer Elkins (1998), Sang et al. (2001) and
Dittmar (1993)
b-sitosterol Sterols Lowering blood cholesterol and
stimulating immune system
Shovic and Whistler (2001) and Wang
et al. (2002)
Citrifolinoside B Iridois Suppressing UVB-induced
Activator Protein-1 (AP-1)
activity
Sang et al. (2001)
Kaempferolm 3-O-b-D-
glucopyranosyl-(1-2)-a-
Lrhamnopyranosyl-(1-6)-b-
D-galactopyranoside
Chlorophyll
derivatives
Might be involved in lowering
blood glucose levels
Sang et al. (2001)
Scopoletin A coumarin
derivative
Anti-proliferative eﬀects on
cancer
Kamiya et al. (2010) and Mohd Zin et al.
(2007)
Fruit Octanoic (caprylic) acid Fatty acid Antifungal Elkins (1998), Dittmar (1993), Wang et al.
(1999, 2002), Mohd Zin et al. (2007),
Jayaraman et al. (2008), Liu et al. (2001)
and Zhang et al. (2014)
Hexanoic acid Antifungal, Antioxidant
Caproic acid Antifungal
Vitamin C Vitamins Antioxidant Zin et al. (2002) and West et al. (2011)
Vitamin E Nutritional
Niacin Nutritional
Manganese, Selenium Trace elements Nutritional Zin et al. (2002) and West et al. (2011)
Asperulosidic acid Iridoid Antibacterial West et al. (2012)
Quercetin Flavonoids Anti-inﬂammatory,
Lipoxygenase inhibitor
Elkins (1998), Sang et al. (2001), Liu et al.
(2001), Morton (1992), Yu (2004) and
Deng et al. (2007b)
2,6-di-O-(b-D-
glucopyranosyl 1-O-
octanoyl-b-D glucopyranose
Fatty acid ester Melanogenesis suppression,
antioxidant
Nelson (2006), Kamiya et al. (2010),
Jayaraman et al. (2008) and Lin et al.
(2013)
6-O-(b-D-glucopyranosyl-1-
O-octanoyl-b-D
glucopyranose
Liu et al. (2001), Wang et al. (1999),
Zhang et al. (2014) and Akihisa et al.
(2012)
Damnacanthal Anthraquinones Anti-cancer Chan-Blanco et al. (2006) and Kamata
et al. (2006)
Americanin A Lignan Potent antioxidant Su et al. (2005)
Root 8-hydroxy-8-methoxy-2-
methyl-anthraquinone,
rubiadin
Anthraquinone Antiviral Elkins (1998), Morton (1992) and Inoue
et al. (1981)
(continued on next page)
Morinda citrifolia (Noni): A comprehensive review 5
Please cite this article in press as: Abou Assi, R. et al.,Morinda citrifolia (Noni): A comprehensive review on its industrial uses, pharmacological activities, and clinical
trialsMorinda citrifolia (Noni): A comprehensive review –>. Arabian Journal of Chemistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.06.018
Table 1 (continued)
Plant part Compound Chemical
classiﬁcation
Activities/uses Reference
1,3-dihydroxy-6-methyl
anthraquinone
Morenone 1 Anti-cancer Elkins (1998) and Solomon (1999)
Morenone 2
Asperuloside (rubichloric
acid)
Iridoid Anti-bacterial Bushnell et al. (1950)
Quercetin Flavonoids Antioxidant, anti-dyslipidemic Mohd Zin et al. (2007) and Mandukhail
et al. (2010)
Scopoletin Coumarin
derivative
Antibacterial Sang et al. (2001) and Jensen et al. (2005)
Damnacanthal Anthraquinones Anti-carcinogenic Nualsanit et al. (2012)
6 R. Abou Assi et al.3.4. Natural source of medicines
Scientists are looking at theM. citrifolia as a natural source for
the medicinal production by using a bioreactor cultivation
technology to produce speciﬁc medicinal compounds at a rate
similar or superior to natural grown M. citrifolia. Data have
shown that casual root cultures ofM. citrifolia could be a use-
ful way for the commercial production of biotechnology based
chemicals such as rubiadin, ﬂavonoids, phenolics and anthra-
quinones (Baque et al., 2012).
The aqueous root extract of Indian M. citrifolia was also
used in nanobiotechnology ﬁeld for the synthesis of ecological
noble metal nanoparticles due to the presence of anthraqui-
nones. Silver nanoparticles were prepared by the reduction
of silver nitrate into silver ions upon adding M. citrifolia root
aqueous extract and incubating for an overnight to yield par-
ticles between 30 and 55 nm with a cytotoxic activity against
the HeLa cell lines (Suman et al., 2013). Gold nanoparticles
were prepared by mixing M. citrifolia root aqueous extract
with aqueous solution of chloroauric acid to produce gold
nanoparticles. This preparation was predicted to have a higher
anticancer activity due to its smaller size (12.17–38.26 nm)
(Suman et al., 2014). However, before proceeding in this drug
development program, a comprehensive phytochemical
proﬁling of M. citrifolia, pharmaco-therapeutics, toxicity and
clinical trials are needed (Singh, 2012).
3.5. Natural source of chemical reagents
Acetone extract of Thai M. citrifolia dried roots was reported
as a source of natural reagents for the ﬂow injection spec-
trophotometric technique in quantitative assays. Extract con-
taining anthraquinones like alizarin was successfully
detecting aluminum at a concentration range of 0.1–
1.0 mg L1 in instant tea samples. Anthraquinone compounds
were acting as a complexing agent by reacting with aluminum
and forming a reddish complex which could be measured at
499.0 nm (Tontrong et al., 2012). The potentials of M. citrifo-
lia in being a green chemical reagent opened a new era of
research in the analytical and biochemical ﬁelds.
3.6. Green insecticidal
The mosquitocidal activity of Indian M. citrifolia was success-
fully proved at various concentrations range (100–500 ppm).Please cite this article in press as: Abou Assi, R. et al.,Morinda citrifolia (Noni): A co
trialsMorinda citrifolia (Noni): A comprehensive review –>. Arabian Journal of ChThe activities of hexane, chloroform, acetone, methanol, and
water leaf extracts were sequentially observed on the develop-
ing phases of malarial vector, Anopheles stephensi, Dengue vec-
tor, Aedes aegypti and Filarial vector culex quinquefasciatus.
The studies were conducted for 24 and 48 h. showing that
methanol extract had the highest larval and pupal mortality
rate (Kovendan et al., 2012). The IndianM. citrifolia leaf etha-
nol extract was also reported for its larvicidal and pupicidal
activities against the malarial vector Anopheles stephensi either
alone at a range of 18.30–97.78 mg/L, or as a combination of
M. citrifolia at a concentration range of 16.73–138.10 mg/L
with Metarhizium anisopliae (an entomopathogenic fungi) at
a concentration range of 150.15–806.67 mg/mL. The combina-
tion therapy showed the highest larval and pupal mortality
rate (Kovendana et al., 2014).
4. Pharmacological activities
According to the European Commission 5th framework pro-
gram quality of life, there are no systematic reviews or meta-
analyses that have been published about the M. citrifolia wide
ranges of therapeutical claims (Pilkington and The CAM-
Cancer Consortium, 2015). In the next paragraph, the dis-
cussed therapeutic indications are linked to a clear scientiﬁc
evidence of either in vitro and in vivo studies, or clinical trials,
with a speciﬁcation about the responsible phytochemical com-
ponent of each activity, as well as the extracting solvent and
the used part of the plant along with its country of origin
and Fig. 2 summarizes the chemical structures of M. citrifolia
most common pharmacologically active ingredients.
4.1. Antimicrobial and antiseptic activity
The anti-microbial activity of Tahitian M. citrifolia fruit in a
methanol partitioned with n-butanol extract was assessed in
an in vitro assay on Escherichia coli, Candida albicans and
Staphylococcus aureus. Candida albican was the most sensitive
to M. citrifolia antimicrobial activity, while Staphylococcus
aureus sensitivity was the lowest. This activity was linked to
the rich iridoid content of the fruit, particularly, deacetylaspe-
rulosidic acid and asperulosidic acid (West et al., 2012).
Another anti-microbial in vitro assay was conducted on metha-
nol, ethyl acetate and hexane Indian M. citrifolia fruit extracts
against a wide range of organisms including the following:
Bacillus subtilis, Staphylococcus aureus, Lactococcus lactis,mprehensive review on its industrial uses, pharmacological activities, and clinical
emistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.06.018
Asperulosidic acid Deacetylasperulosidic acid Aucubin Alizarin
Asperulosidic Scopolamine 3,3'-bisdemethylpinoresinol Americanin A
Ursolic acid Catechin Epicatechin Rutin
Glucuronoic acid Galactose Arabinose Rhamnose
(6-O-(beta-D-glucopyranosyl)-1-
O-octanoyl-beta-D-glucopyranose
Damnacanthal Limonene Butylated 
hydroxytoluene 
Figure 2 Summary of the chemical structures of M. citrifolia most common pharmacologically active ingredients.
Morinda citrifolia (Noni): A comprehensive review 7Streptococcus thermophilus, Pseudomonas aeruginosa,
Salmonella typhi, Escherichia coli, Vibrio harveyi, Klebsiella
pneumonia, Shigella ﬂexneri, Salmonella paratyphi A,
Aeromonas hydrophila, Vibrio cholera, Chromobacterium vio-
laceum, and Enterococcus faecalis. Among the three tested
extracts, methanol extract was the most effective, ethyl acetate
was effective against all the tested micro-organisms except for
Pseudomonas aeruginosa and Klebsiella pneumonia, and hexane
extract was ineffective against all tested microorganisms
(Jayaraman et al., 2008). The antimicrobial activities of the
Australian M. citrifolia leaf against Salmonella, Enterica sero-
var typhi (S76), Staphylococcus aureus (B313) and Myco. phlei
CSL, were attributed to the presence of phenolic compoundsPlease cite this article in press as: Abou Assi, R. et al.,Morinda citrifolia (Noni): A co
trialsMorinda citrifolia (Noni): A comprehensive review –>. Arabian Journal of Chsuch as acubin, l-asperuloside, alizarin and scopoletin
(Atkinson, 1956). On the other hand, an in vitro study reported
M. citrifolia as an oral antiseptic through teeth inoculation
with Enterococcus faecalis at 37 C in a CO2 atmosphere for
30 days, and then treating them with Tahitian noni fruit juice
(TNJ), NaOCl, chlorhexidine gluconate (CHX), and
TNJ/CHX respectively, followed by a ﬁnal ﬂush with 17%
ethylene diamine tetra acetic acid (EDTA). Upon scanning
the teeth with electron microscopy, and examining the
removed smear layer, TNJ efﬁcacy found to be similar to
NaOCl when it is used together with EDTA, authors recom-
mended preclinical and clinical trials to evaluate TNJ biocom-
patibility and safety (Murray et al., 2008). The previous resultsmprehensive review on its industrial uses, pharmacological activities, and clinical
emistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.06.018
8 R. Abou Assi et al.were conﬁrmed with another study which additionally revealed
TNJ safety on the micro-hardness property of root canal den-
tin (Saghiri et al., 2013).
4.2. Antifungal activity
The antifungal properties of IndianM. citrifolia fruit extract in
three different solvents, methanol, ethyl acetate and hexane
were tested in an in vitro assay on different fungi including
Candida albicans, Aspergillus niger, Trichophyton mentagro-
phytes, Penicillium species, Fusarium species, Aspergillus fumi-
gates, Rhizopus species, Aspergillus ﬂavus, and Mucor species.
The maximum inhibition was in the methanol and ethyl acet-
ate extract of 79.3% and 62.06%, respectively against
Trichophyton mentagrophytes, while almost 50% inhibition
was recorded in the methanol extract against Penicillium,
Fusarium and Rhizopus species, and none of the extracts were
active against either Candida albicans or Aspergillus species
(Jayaraman et al., 2008).
Despite the fact that in vitro results for anti-bacterial and
anti-fungal studies are promising yet further in vivo and clinical
research are highly recommended using different routes of
administrations.
4.3. Antioxidant activity
Australian M. citrifolia fruit juice showed an anti-oxidant
activity 2.8 and 1.4 times higher than vitamin C and pyc-
nogenol, respectively. This antioxidant activity was similar to
grape seed powder at the daily dose recommended by U.S.
RDAs and manufacturers (Atkinson, 1956). Neolignan and
americanin A were the potent antioxidant constituent of the
American M. citrifolia fruit (Su et al., 2005). The optimum
magnitudes of radical scavenging activity (RSA), and total
phenolic content of Malaysian seedless M. citrifolia fruit
methanol extract were 55.60% and 43.18 mg GAE/10 g,
respectively (Krishnaiah et al., 2015). In other study, M. citri-
folia anti-oxidant activity was evaluated as a natural anti-
pigmentation agent by observing the effect of 50% ethanol
extracts of Tahitian M. citrifolia fruit ﬂesh, leaves, and seeds,
on the tyrosinase enzyme responsible for controlling the pro-
duction of melanin. The in vitro test was carried out using
tyrosinase inhibitory assay, showing that seed extract had
stronger tyrosinase inhibitory (from 20 to 500 lg/ml) and
antioxidant activity than the fruit (500 lg/ml), while leaf
extract did not have any tyrosinase inhibitory activity at any
concentration. The tyrosinase inhibitory activity was linked
to the presence of lignans in M. citrifolia, particularly 3,30-bis
demethylpinoresinol and americanin A (Masuda et al., 2009).
The same seed extract was found to have anti-photoaging
activity at concentrations ranging from 0.5 to 1.0 mg/ml
(Matsuda et al., 2013), and also inhibited blood hemagglutina-
tion at concentrations ranging from 50 to 500 lg/ml (Matsuda
et al., 2011); ursolic acid was the responsible chemical for the
both activities.
M. citrifolia anti-oxidant property was also linked to other
health enhancements activities. In an in vitro evaluation of
methanol, chloroform, ethanol, butanol and aqueous extract
of Indonesian M. citrifolia fruit, all extracts were able to inhi-
bit Low-density lipoprotein (LDL) oxidation due toM. citrifo-
lia lignans, such as americanol A, americanin A, americanoicPlease cite this article in press as: Abou Assi, R. et al.,Morinda citrifolia (Noni): A co
trialsMorinda citrifolia (Noni): A comprehensive review –>. Arabian Journal of Chacid A, morindolin, and isoprincepin (Kamiya et al., 2004).
Other in vitro study suggested Malaysian M. citrifolia leaf
ethanol extract was a highly effective natural anti-obesity sup-
plement than its fruit. Leaf and fruit methanol extracts inhib-
ited the lipoprotein lipase activity 66%± 2.1 and
54.5%± 2.5%, respectively. Both extracts contain high levels
of phenolic constituents including catechin, epicatechin and
rutin which acted synergistically to demonstrate this activity
(Pak-Dek et al., 2008). Furthermore, Tahitian M. citrifolia
juice was able to reduce obesity related to insulin resistance
in an in vitro mouse muscle cells C2C12 culture, by inhibiting
the reactive oxygen species and mitochondrial damage
(Nerurkar and Eck, 2008).
A clinical study was carried out on twenty-two participants
(16 women and 6 men), aged between 18 and 65 years old for
12 weeks trial of a weight-loss program with a ﬁxed study fac-
tors including Tahitian M. citrifolia -based dietary supple-
ments (US brand), daily calorie reduction, and exercise. All
participants experienced weight loss with signiﬁcant decrease
in fat mass without side effects. However, the researchers sug-
gested that further clinical studies should be carried out to
include more male participants, and ethnic diversity (Palu
et al., 2011). Antidyslipidemia activity was related to M. citri-
folia antioxidant property in the aqueous-ethanol extracts of
its Indian fruits, leaves, and roots in Sprague–Dawley rats
and mice of either sex, all these different parts extracts caused
signiﬁcant reduction in total cholesterol, triglyceride (TC), low
density lipoprotein-cholesterol, atherogenic index and
TC/HDL ratio. There were no behavioral changes, toxicity
or mortality occurred up to 10 g/kg of M. citrifolia intake, as
compared to control group (Mandukhail et al., 2010).
Hepato-protective effects M. citrifolia was also afﬁned to
anti-oxidant effects in its Taiwanese fermented fruit juice at
a dose range of 3–9 mL NJ/kg BW on hamsters fed with a
high-fat diet (Lin et al., 2013).
4.4. Anti-inﬂammatory activity
In an in vitro study, the anti-inﬂammatory activity was
detected in the Costa Rican M. citrifolia fruit juice by measur-
ing its direct inhibitory activities on cyclooxygenase (COX)-1
and -2 (Dussossoy et al., 2011). The in vivo study on
Tahitian M. citrifolia fruit juice showed a reduction in the
induced carrageenan paw edema in rats, revealing a strong
anti-inﬂammatory effect comparable to that of non-steroidal
inﬂammatory drugs, such as acetylsalicylic acid, indomethacin
and celecoxib, without side effects (Su et al., 2001). Tahitian
M. citrifolia seeds oil showed topical anti-inﬂammatory activ-
ity by inhibiting both COX-2 and 5-LOX enzymes in an
in vitro assay at concentrations of 0.5 and 1 mg/ml (Palu
et al., 2012). The topical safety of the M. citrifolia seed oil
was evaluated on 49 adult volunteers using the patch test
whereas topical comedogenic effect of the seed oil was studied
on 23 Caucasian adolescent volunteers. Both studies were con-
ducted for four weeks, and results indicated that the topicalM.
citrifolia seed oil was safe and non-comedogenic, in addition to
showing a very little risk of causing allergic dermatitis which
could be due to seed high fatty acids content, mainly linoleic
acid (Palu et al., 2012).
A randomized double-blind placebo-controlled trial using a
M. citrifolia dietary supplement (U.S brand) was ﬁrstmprehensive review on its industrial uses, pharmacological activities, and clinical
emistry (2015), http://dx.doi.org/10.1016/j.arabjc.2015.06.018
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women completed the study. The aim of the study was to ﬁnd
out the potential natural anti-inﬂammatory efﬁcacy of M.
citrifolia. This study included some variables such as age, par-
ity, body mass index, pain, menstrual blood loss, hemoglobin,
packed cell volume and erythrocyte sedimentation rate before
and after treatment. Patients were observed for three
menstrual cycles after being exposed to 400 mg of M. citrifolia
capsules or placebo (38 in the placebo group and 42 in the
M. citrifolia group) and there were no signiﬁcant differences
in any of the variables studied between treated and placebo
group, further studies using higher doses of M. citrifolia with
a larger sample size were recommended (Fletcher et al., 2013).
4.5. Anti-arthritic activity
An Indian brand of M. citrifolia fruit juice was orally admin-
istered to arthritic rats at doses 1.8 ml/kg and 3.6 ml/kg, and
showed a dose dependent signiﬁcant reduction in paw thick-
ness, arthritic index, secondary lesions, mononuclear inﬁltra-
tion and pannus formation. Similar changes were also
recorded by the administration of indomethacin except for
the reduction of secondary lesions. The anti-arthritic activity
could be due to the presence of ﬂavonoids and phenols
(Saraswathi et al., 2012). Precise investigations can add a
therapeutical value by specifying the chemicals owning such
activities and their effective and safe doses.
4.6. Anti-cancer activity
M. citrifolia natural components are mostly reported as a nat-
ural anticancer cure where sulphated polysaccharide stops
metastasis by destabilizing the interaction between gly-
cosaminoglycan and certain proteins (Liu et al., 2000) while
damnacanthal inhibits the formation of tumors either by inter-
fering with the growth of ras gene activation (Hiramatsu et al.,
1993), or by increasing apoptosis in human colorectal cancer
cell lines (Nualsanit et al., 2012). Alizarin has an antiangio-
genic effect through blocking blood circulation to malignant
tumors. Limonene prevents mammary, liver, and lung cancers
by stimulating thymus gland to secrete more T cells which
destroys the carcinoma cells. Last but not the least, ursolic acid
inhibits the growth of cancerous cells and induces apoptosis by
modulating the body immune process (Lv et al., 2011).
4.6.1. In vitro studies
ThaiM. citrifolia fresh and dried leaf dichloromethane extracts
were reported to be more effective and probably safer in treat-
ing cancer than M. citrifolia pure compounds such as
damnacanthal, rutin, and scopoletin due to the extracts higher
safety ratios. Four human cancer cell lines (epidermoid carci-
noma, cervical carcinoma, breast carcinoma and hepatocellu-
lar carcinoma), and a Vero (African green monkey kidney)
cell lines were used in the study. Both M. citrifolia extracts
showed an inhibitory effect on epidermoid carcinoma and cer-
vical carcinoma cells, while the pure compounds, rutin and
scopoletin, showed lower anti-proliferative effects on all
human cancer cell lines. However, only damnacanthal had
potent cytotoxic effects against all human cancer cell lines as
well as African green monkey kidney cell lines (Kamiya
et al., 2010).Please cite this article in press as: Abou Assi, R. et al.,Morinda citrifolia (Noni): A co
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extract from the root of Chinese M. citrifolia were cultured
separately in a blood serum with osteoblasts (induced by
trans-retinoic acid) to assess their cytotoxic role. The pure
polysaccharides showed higher anticancer activity than the
root aqueous extract (Li et al., 2008b), yet no speciﬁc screening
was conducted on the type and structure of these polysaccha-
rides. Furthermore, the damnacanthal which was isolated from
the roots of Thai M. citrifolia had anticolorectal cancer activ-
ity as it showed a systematic cancer-suppressing capability in
colorectal tumorigenesis (Nualsanit et al., 2012). Likewise, sci-
entists extracted and scanned 18 different anthraquinones
from the air dried powders of Hawaiian M. citrifolia roots
for its anti-cancer activity using MTT cell proliferation assay.
All the anthraquinones showed an anti-proliferation activity
on both human lung cancer and colon cancer cells, speciﬁcally
1,3-dihydroxy-2-formylanthraquinone had the highest effects
(Lv et al., 2011). Anthraquinone anti-cancer activity is not
fully addressed, but it could be due to either aldehyde or meth-
oxymethyl group at the C-2 position (Kamiya et al., 2010).
Anti-genotoxic potential of M. citrifolia juice was tested on
human lymphocyte cultures at 200, 250, 300, 350 ll/ml per cul-
ture, showed a potent anti-genotoxic activity reﬂecting its pos-
sible anti-carcinogen effects at the initiation stage (Li et al.,
2008b), however, further studies should specify the M. citrifo-
lia juice ingredient(s) which is causing this effect, taking in con-
sideration to evaluate wider concentrations range than the
previously used ones on human lymphocyte cultures or even
studying other models.M. citrifolia fruits ethanol extract from
Kauai and Hawaii islands contains a polysaccharide rich sub-
stances (i.e. glucuronic acid, galactose, arabinose and rham-
nose), which had immunomodulatory and anti-tumor effects
on Lewis lung carcinoma cell lines (Hirazumi and Furusawa,
1999). Other two glycosides (6-O-(b-D-glucopyranosyl)-1-O-
octanoyl-b-D-glucopyranose and asperulosidic acid) which
were isolated from M. citrifolia fruit juice, showed an efﬁcacy
in suppressing the induced transformation in mouse epidermal
JB6 cell line (Liu et al., 2001).
The crude extract of Hawaiian M. citrifolia fruit was
reported to inhibit neuroblastoma (36%) and breast cancer
(29%) cell lines effectively in comparison to hamster (6%) or
human laryngeal (13%) cell lines, but it had no effects on green
monkey kidney (0%) cell line (Arpornsuwan and Punjanon,
2006). In addition, the fermented Hawaiian M. citrifolia juice
acted as an anti-proliferative for dendritic cells by stimulating
both splenocytes, and B cells in order to produce IgG and IgM
(Wong, 2004).
HeLa and SiHa cell lines were treated with either IndianM.
citrifolia fruit juice, cisplatin (an anti-cervical cancer treat-
ment), or their combination and showed that all the tested
preparations were able to induce apoptosis in the examined cell
lines. However, cisplatin showed slightly higher cell killing rate
compared to M. citrifolia fruit juice, whereas their
combination showed additive effects (Gupta et al., 2013).
Furthermore, two lignans, 3,30-bisdemethylpinoresinol
(5 lM) and americanin A (200 lM), from the Tahitian M.
citrifolia seed ethanol extract were evaluated for melanogenesis
inhibitory properties, using B16 murine melanoma cells as a
melanogenesis test model and a-melanocyte hormone
(a-MSH) to stimulate the cells, before incubating them for
72 h. Both lignans were able to inhibit a-MSH-stimulated
melanogenesis, however, 3,30-bisdemethylpinoresinol effectmprehensive review on its industrial uses, pharmacological activities, and clinical
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through tyrosinase suppression (Masuda et al., 2012).
4.6.2. In vivo studies
Rats with artiﬁcially induced cancer in speciﬁc organs were fed
with 10% M. citrifolia juice in their drinking water. After one
week DNA-adduct formation was reduced depending on sex
and organ. The reduction rates in organs of female rats were
heart 30%, liver 42%, lungs 41% and kidneys 80% whereas
the reduction rates in organs of male rats were heart 60%, liver
70%, lungs 50% and kidneys 90% (Chan-Blanco et al., 2006).
In other study, mice subjected to sarcoma tumor cells demon-
strated synergistic beneﬁcial effects after being treated with
Hawaiian M. citrifolia fruit ethanol precipitate combined with
some anti-cancer drugs including cisplatin, adriamycin,
mitomycin-C, bleomycin, etoposide, 5-ﬂuorouracil, vincristine
or camptothecin. However, no beneﬁcial effects were recorded
when M. citrifolia combined with paclitaxel, cytosine arabi-
noside, or immunosuppressive anticancer drugs such as
cyclophosphamide, methotrexate or 6-thioguanine. In con-
trast, mice treated with the fruit ethanol precipitate alone
showed a cure rate of 25–45% (Furusawa et al., 2003). The
freeze-dried Tahitian M. citrifolia fruit was also reported to
prevent chemically induced tumorigenesis in rat esophagus
(Stoner et al., 2010).
Li et al. (2008a,b) investigated antitumor effect of
fermented Hawaiian NoniM. citrifolia exudate (500 ll/mouse/
day) administered intraperitoneally to sarcoma 180 ascites
mouse model. It was discovered that more than 85% of nude
mice were tumor free in one and half months after tumor inoc-
ulation, versus 100% of the control mice died within 30 days of
tumor inoculation (Li et al., 2008a). Another antitumor study
was conducted on three groups of eight mice each was induced
with Ehrlich ascites tumor. The ﬁrst, second and third groups
were given oral M. citrifolia juice (a commercial product from
the Netherlands), doxorubicin (a potent anticancer drug), and
a combination of both, respectively. The results suggested that
oral M. citrifolia fruit juice may be useful in the treatment of
breast cancer, either alone or in combination with doxorubicin
(Taskin et al., 2009). Moreover, TahitianM. citrifolia juice sig-
niﬁcantly reduced tumor weight and volume in mice, thus it
might be useful in enhancing the treatment responses in
women with the existing HER2/neu breast cancer (human epi-
dermal growth factor receptor 2 gene) (Clafshenkel William
et al., 2012). In contrast, Tahitian M. citrifolia fruit juice
administered to MMTV-neu transgenic mice had no effect
on mammary tumor latency, incidence, multiplicity, and meta-
static, suggesting that theM. citrifolia juice did not increase or
decrease breast cancer risk in women, but it could be taken as a
dietary supplement for other beneﬁts (Clafshenkel William
et al., 2012). Thus, further work is highly recommended to
clarify the role of Tahitian M. citrifolia juice and its other
extracts in treating breast cancer.
4.6.3. Clinical trials
In one trial, Tahitian M. citrifolia fruit juice with a dose of 1
and 4 oz daily had reduced cancer risk among 203 heavy cigar-
ette smokers. The data showed a signiﬁcant reduction of aro-
matic DNA adducts levels in all participants by 44.9% after
drinking the juice for 1 month. Dose-dependent analyses of
aromatic DNA adduct levels revealed a reduction of 49.7%Please cite this article in press as: Abou Assi, R. et al.,Morinda citrifolia (Noni): A co
trialsMorinda citrifolia (Noni): A comprehensive review –>. Arabian Journal of Chin the 1-oz dose group, and 37.6% in the 4-oz dose group.
However, gender-speciﬁc analyses showed no signiﬁcant differ-
ences in the 4-oz dose groups, while in the 1-oz dose group
showed 43.1% reduction in females compared to 56.1% in
males. The suggested mechanism of cancer reduction was by
blocking carcinogen-DNA binding, or excising DNA adducts
from genomic DNA (Wang et al., 2009b).
Only two cancer cases were reported to use M. citrifolia.
Case 1 was about a 69 year old male with gastric cancer who
was predicted to die within few months without surgical inter-
vention. The patient chose to take homemadeM. citrifolia fruit
juice over the surgical operation and his condition improved
within a month. After 6 months he stopped the self-
treatment, and seven years later he did not have any gastric
symptoms. However, a biopsy showed histological similarity
to his original cancer and hence, he started takingM. citrifolia
juice again but the outcome was not reported. Case 2 was about
a 64 year old man with gastric cancer who underwent a gastrec-
tomy. The cancer had spread to 17 out of 28 examined lymph
nodes, and he was given 5 years to live. The patient consumed
a homemade M. citrifolia juice and lived additional 16 years
until he died at the age of 80 due to gastric cancer (Wong, 2004).
In a Phase I human clinical trial conducted at the Cancer
Research Centre in Hawaii, 29 advanced cancer patients ﬁrst
started a daily dosage of 4 capsules (500 mg/capsule) from a
freeze dried M. citrifolia fruit, and later it was increased up
to 20 capsules (10 g) during a total 4 weeks trial which showed
no tumor regression, but only a decrease in fatigue and pain
interference, while the recorded maximum tolerated dose was
six capsules four times daily (12 g) (Issell et al., 2009). The clin-
ical trials’ results are showing no clear role of M. citrifolia in
either preventing or healing cancer disease, patients’ number
should be addressed on a larger scale, with wider parameters
and speciﬁcations to ameliorate the understanding of applying
M. citrifolia in therapeutic and prophylactic anti-cancer
medicine.
4.7. Antidiabetic activity
Indian M. citrifolia commercial fruit juice was administered
orally to induced steroid diabetic (diabetes type 2) female
Wistar rats, at a dose of 1.8 and 3.6 ml/kg for 10 days. The
blood glucose level was signiﬁcantly decreased compared to
control induced diabetic rats by dexamethasone. At higher oral
dose (3.6 ml/kg, twice a day)M. citrifolia fruit juice had better
results than rosiglitazone, but caused liver damage in rats
(Puranik et al., 2013). On the other hand, fermented juice of
South American M. citrifolia also controlled blood sugar
induced diabetic rats by streptozotocin. Diabetic standard ani-
mals, treated with hypoglycemic drug, glibenclamide, while
diabetic experimental animals treated with 2 ml/kg M. citrifo-
lia twice a day for 20 days exhibited a signiﬁcant reduction in
blood glucose level of 125 mg/dl and 150 mg/dl, respectively,
as compared to untreated diabetic rats with fasting blood
sugar of 360.0 mg/dl (Shivananda Nayak et al., 2011).
Hypoglycemic activity of Tahitian M. citrifolia fruit Juice
was investigated by administering the juice to male Sprague–
Dawley rats at a dose of 1 ml/150 g body weight, twice daily
for 4 weeks prior to diabetic induction using alloxan. After
induction, a rise in blood glucose levels occurred but followed
by a steady decline due to M. citrifolia juice prophylaxis
against the diabetogenic agent, alloxan (Horsfal et al., 2008).mprehensive review on its industrial uses, pharmacological activities, and clinical
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ties of Hawaiian fermentedM. citrifolia fruit juice were associ-
ated with the ability to modulate transcription factors (FoxO1)
in order to regulate the gluconeogenesis process. Fermented
M. citrifolia juice supplement at a dose of 1.5 ll/g body
weights, twice a day for 12 weeks improved glucose and insulin
tolerance as well as fasting blood glucose level in male mice.
Gluconeogenic genes which are regulated by insulin including
phosphoenolpyruvate C kinase and glucose-6-phosphatase
were also inhibited by more than 80% (Nerurkar et al.,
2012). It was suggested that M. citrifolia antidiabetic effect
might be due to the stimulatory effect on the remnant ß-cells
to secrete more insulin (Mustaffa et al., 2011). Saponins as well
as ﬂavonoids inM. citrifolia fruit such as rutin may also act as
a secretagogue by enhancing insulin secretion (Shivananda
Nayak et al., 2011). M. citrifolia is showing promising in vivo
results as a natural antidiabetic agent; however scientist should
pay a great concern on its safety particularly liver. If the doses
are adjusted within a safe range and a proven efﬁcacy, preclin-
ical studies will be recommended.
4.8. Wound healing activity
Fresh TahitianM. citrifolia leaf juice (1 mg/ml), its leaf ethanol
extract (10–200 lg/ml), and its methanol and hexane fractions
(10–200 lg/ml), were investigated for their topical wound heal-
ing properties. Receptors involved in wound healing such as
platelet-derived growth factor (PDGF) and adenosine A2A
receptor were studied on male mice. All M. citrifolia extracts
showed a wound healing activity at a concentration dependent
manner; however, leaf methanol extract signiﬁcantly increased
wound closure and reduced the half closure time in treated mice
compared to the control, suggesting that the probable mecha-
nism underlying this effect was the ligand binding to
PDGF/A2A receptor which promoted wound closure (Palu
et al., 2010). The promising results in this study should be con-
ﬁrmed through further in vivo studies on various models to
draw a sharp conclusion about the healing mechanism.
4.9. Memory enhancing activity
Observations in a scopolamine induced memory impairment
mice model suggested that Indian M. citrifolia dry fruit may
be useful in enhancing memory at concentration range of 5–
400 lg/ml. The fruit ethanol extract and its ethyl acetate frac-
tion were containing rutin, scopoletin and quercetin, while the
chloroform fraction was containing rutin and scopoletin, have
showed positive effects. However, butanol fraction containing
rutin alone had no effect. The mechanism of action was
thought to be by inhibiting acetylcholinesterase activity, and
the enhancement of the cerebral circulation (Pachauri et al.,
2012). Results should be conﬁrmed by further research to jus-
tifyM. citrifolia effects on different in vivo models with precise
illustration of chemicals responsible of such activity and the
precise mechanism of memory enhancement.
4.10. Anxiolytic and sedative activity
A preliminary in vitro study revealed that TahitianM. citrifolia
freeze dried fruit methanol extract had anxiolytic and sedative
effects by showing an afﬁnity to the gamma-aminobutyric acidPlease cite this article in press as: Abou Assi, R. et al.,Morinda citrifolia (Noni): A co
trialsMorinda citrifolia (Noni): A comprehensive review –>. Arabian Journal of ChA (GABAa) inhibitory neurotransmitter receptors at a concen-
tration of 100 lg/ml. The action could be due to the presence
of competitive ligand(s) bind to the GABAa receptor as an
agonist that induced anxiolytic and sedative effects.
However, in vivo studies and clinical trials were recommended
by the authors to conﬁrm the newly reported activity (Deng
et al., 2007a). Furthermore, a US brand of TahitianM. citrifo-
lia fruit juice at 10 ml/kg/day showed to have an in vivo brain
protection from the stress-induced impairment of cognitive
function on male ICR mice. This beneﬁcial effect may be
partly mediated by the improvement in angiogenesis induced
by M. citrifolia (Muto et al., 2010). In an in vivo study on
the Swiss albino mice, Malaysian M. citrifolia unripe dried
fruit methanol extract was also reported for its anti-
dopaminergic effects at 1, 3, 5, 10 g/kg oral doses. The sug-
gested mechanism of action was due to the possible inhibition
of the Methamphetamine-induced stereotypy behavior in a
dose dependent manner. Further studies to isolate and charac-
terize the responsible compounds for anti-psychiatric disorders
were recommended (Pandy et al., 2012).
4.11. Analgesic activity
Tahitian M. citrifolia fruit juice was reported for its analgesic
effect in rats by using the hotplate assay. The rats tolerated
more pain after feeding with 10% or 20% M. citrifolia juice
(Wang et al., 2002). In another study, the lyophilized aqueous
African M. citrifolia dry root extract had also demonstrated
analgesic properties at dose of 800 mg/kg given intraperitoneal
injections. The analgesic activity was observed using three
methods, the antagonistic action of naloxone, the writhing test,
and the hotplate assay (Younos et al., 1990).
4.12. Gastric ulcer healing activity
Thai dried mature unripe M. citrifolia fruit aqueous extract
was reported for its in vivo gastro-esophageal anti-
inﬂammatory effects in rats at a range of 0.63–2.50 g/kg, with
possible mechanisms of reducing the formation of acute gastric
lesions, blocking the esophagus reﬂux and acting as an antise-
cretory agent similar to ranitidine and lansoprazole
(Mahattanadul et al., 2011). In an open-label, two-period
crossover study, 20 healthy volunteers from 18 to 45 years
old were given a single-dose of ThaiM. citrifolia fruit aqueous
extract containing 25.15 ± 0.11 lg/ml scopoletin. After 30 min
the volunteer were given 1 tablet of ranitidine (300 mg) and
blood samples were collected for 12 h. The results showed that
M. citrifolia acted as a ranitidine absorbance inducer due to
the presence of scopoletin which stimulated the 5-HT4 recep-
tor. Further clinical trial using more patients having speciﬁc
gastric motility defect or symptoms was recommended to
provide stronger evidence (Nima et al., 2012).
4.13. Antiemetic activity
To study the antiemetic activity of M. citrifolia, a preliminary
randomized double blinded, placebo-controlled clinical trial
was done on 100 patients with a high risk of postoperative
nausea and vomiting (PONV), their ages were 18–65 years
old. In one group Thai M. citrifolia fruit was given 1 h.
before the surgery at a dose of 600 mg, beside that themprehensive review on its industrial uses, pharmacological activities, and clinical
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well as the post-operative analgesia. The results revealed that
patients who received M. citrifolia experienced signiﬁcantly
less nausea during the ﬁrst 6 h compared to the placebo
group (Prapaitrakool and Itharat, 2010), to understand this
activity further in vitro, in vivo and clinical trials should be
conducted to specify by which mechanism(s) M. citrifolia is
acting as an antiemetic, and what if it could be used in
reducing emetic symptoms caused by different cases rather
than PONV.Table 2 The list of M. citrifolia pharmacological activities along w
Plant part Activity In vitro
Fruit Intracanal irrigant X
Fruit Anti-viral X
Fruit, leaf Anti-microbial
X
Fruit Anti-fungal X
Fruit, leaf, root Anti-dyslipidemia
Fruit, leaf Anti-oxidant
X
Fruit Memory dysfunction
Fruit, root Analgesic activity
Fruit, leaf, seed Anti-inﬂammatory
X
Fruit Anti-arthritic X
Fruit, leaf, root Anti-cancer X
Fruit, leaf Anthelminthic activity X
Fruit Source of trace elements X
Fruit Stress reduction
Fruit Anxiolytic and Sedative X
Fruit Probiotic activity X
Fruit, leaf Anti-obesity X
Fruit Hepatoprotective agent
Fruit Immunological stimulator X
Fruit Antisecretory proton pump inhibitor
Seed Antithrombotic eﬀect
Seed Anti photoaging agent X
Seed Anti-wrinkle formation X
Seed, Fruit Anti-pigmentation X
Fruit Anti-psoriasis
Fruit Antidiabetic activity
Fruit Antipsychotic activity
Fruit Antiemetic activity
Fruit Osteoporosis and hearing problems
Leaf Wound healing activity X
Fruit Gout healing factor X
Leaf Anti-tubercular activity X
Please cite this article in press as: Abou Assi, R. et al.,Morinda citrifolia (Noni): A co
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The in vitro bioassay of xanthine oxidase (XO) inhibiting
effects revealed that the Tahitian noni juice (TNJ) is having
a dose dependent natural anti-gout and anti-hyperuricemic
effects. The half maximal inhibitory concentration (IC50) of
M. citrifolia was 3.8 mg whereas IC50 of allopurinol was
2.4 lm. The concentrated methanol extract of this fruit juice
at concentration of 0.1 mg/ml exhibited higher XO enzyme
inhibition rate (64%) compared to XO enzyme inhibition rateith their in vitro, in vivo and clinical trials.
In vivo Clinical
trial
Reference
Murray et al. (2008) and Saghiri et al. (2013)
Kamata et al. (2006)
West et al. (2012), Jayaraman et al. (2008) and
Atkinson (1956)
Jayaraman et al. (2008)
X Mandukhail et al. (2010)
Su et al. (2005), Krishnaiah et al. (2015) and
Nerurkar and Eck (2008)
X Pachauri et al. (2012)
X Wang et al. (2002) and Younos et al. (1990)
X X Dussossoy et al. (2011), Su et al. (2001), Palu
et al. (2012) and Fletcher et al. (2013)
Saraswathi et al. (2012)
X X Chan-Blanco et al. (2006), Kamiya et al.
(2010), Liu et al. (2001), Nualsanit et al.
(2012), Lv et al. (2011), Li et al. (2008b),
Hirazumi and Furusawa (1999),
Arpornsuwan and Punjanon (2006), Wong
(2004), Gupta et al. (2013), Masuda et al.
(2012), Furusawa et al. (2003), Stoner et al.
(2010), Li et al. (2008a), Taskin et al. (2009),
Clafshenkel William et al. (2012), Wang et al.
(2009b) and Issell et al. (2009)
X Brito et al. (2009)
Rybak and Ruzik (2013)
X Muto et al. (2010)
Deng et al. (2007a)
Wang et al. (2009a)
X Pak-Dek et al. (2008) and Palu et al. (2011)
X Lin et al. (2013)
X Krishnaiah et al. (2012) and Palu et al. (2008)
X Mahattanadul et al. (2011) and Nima et al.
(2012)
X Masuda et al. (2009)
Masuda et al. (2009)
Masuda et al. (2009)
Masuda et al. (2009)
X Okamoto (2012)
X Puranik et al. (2013), Shivananda Nayak et al.
(2011), Horsfal et al. (2008) and Nerurkar
et al. (2012)
X Pandy et al. (2012)
X Prapaitrakool and Itharat (2010)
X Langford et al. (2004)
X Palu et al. (2010)
X Palu et al. (2009)
Saludes Jonel et al. (2002)
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authors recommended further studies to isolate the active com-
pounds, and to conduct clinical trials in an aim of supporting
this hypothesis (Palu et al., 2009).
4.15. Anti-psoriasis healing activity
M. citrifolia was reported to act as an anti-psoriasis healing
factor in a 31-year old man who received treatment ofM. citri-
folia fruit powder (4 g/day) and a weekly methotrexate. After
one month treatment, his psoriatic skin lesions signiﬁcantly
improved. This could be due to the immune-modulation effect
of both M. citrifolia and methotrexate on skin lesion
(Okamoto, 2012). So far, this is the only case report about that
activity, thus, such cases should be deeply investigated on
in vitro, in vivo and clinical scales.
4.16. Immunity enhancing activity
The immunity enhancement activity of both Tahitian and
commercial M. citrifolia fruit juices was reported in an
in vivo study on mice, suggesting that M. citrifolia is modulat-
ing the immune system by activating the CB2 receptors, and
suppressing the interleukin-4, as well as increasing the produc-
tion of interferon gamma cytokines. However, authors recom-
mended further in vivo and clinical research to illustrate the
dosage and actual mode of action of M. citrifolia on the
immune system (Palu et al., 2008).
4.17. Anti-viral activity
M. citrifolia fruit component damnacanthal showed to have an
in vitro anti-viral activity via inhibiting one of the human
immunodeﬁciency viruses type 1 (HIV-1) accessory
proteins in a Hela cells through an unknown mechanism.
Authors suggested further studies to elucidate the anti-viral
mechanism of M. citrifolia that could be useful in assessing
the treatment of HIV-1 and other viral diseases (Kamata
et al., 2006).
4.18. Anti-parasitic activity
BrazilianM. citrifolia fruit aqueous extract at 50.1 mg/mL and
ethanolic extract at 24.6 mg/mL were given for three days to
chickens naturally infected by Ascardiagalli. The aqueous
extract showed lower parasite mortality rate (27.08%) than
ethanol extract (66.67%), and the authors recommended
repeating the in vivo experiment using higher concentrations
(Brito et al., 2009).
4.19. Anti-tuberculosis activity
The Filipino M. citrifolia leaves ethanol extract and hexane
fractions at 100 lg/ml reported to have an anti-tubercular
activity in Mycobacterium tuberculosis cultures, with inhibi-
tion rates of 89% and 95% respectively. It is suggested that
the activity may come from E-Phytol compounds, which is a
mixture of ketosteroids, and epidioxysterol (Saludes Jonel
et al., 2002). Future studies should select a proper positive con-
trol to assess this activity.Please cite this article in press as: Abou Assi, R. et al.,Morinda citrifolia (Noni): A co
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Langford et al. (2004) investigated the ability of M. citrifolia
fruit juice to enhance osteoporotic conditions and otoscopic
deﬁciencies by conducting a pilot health survey using SF-36
measurements. Eight participants consumed 2 oz of either a
placebo or aM. citrifolia juice (US brand), along with calcium
supplement, two times a day for 3 months. The results showed
an increase in bone reconstruction which is probably due to a
slight increase in the mean value of the osteoclastic activity
speciﬁc marker, the deoxypyridinoline crosslinks. The oto-
scopic evaluation showed a limited impact on hearing, with a
possible prophylactic effect at the 8000 Hz sensorineural
domains; however authors recommended further studies with
a larger sample size and over longer time periods (Langford
et al., 2004).
Table 2 shows the kinds of investigations (in vivo, in vitro
and clinical trials) conducted on leaf, fruit seed and root of
M. citrifolia.
5. Conclusion
M. citrifolia has been used as a medicine for the overall main-
tenance of a good health as well as the prevention of some dis-
eases including skin, brain, GIT, heart, liver and cancer. Till
date, the only information available for daily recommended
oral dose of M. citrifolia is 2 g; however, there is no informa-
tion on recommended doses range for topical preparations. It
is important to understand thatM. citrifolia properties require
further extensive studies in terms of identiﬁcation of the active
compounds, their speciﬁc mechanism of action and safety. In
addition, more in vivo and clinical studies are required with a
signiﬁcant number of subjects and a wider range of concentra-
tions especially in the cancer ﬁeld. Since further studies are rec-
ommended on M. citrifolia and its products, thus they should
be used with caution particularly for customers with concomi-
tant illness and medications. Companies which are producing
M. citrifolia products should provide relevant information
regarding the bioactive components of M. citrifolia and any
extra nutritional elements added to the products, along with
their concentrations in order to arouse a sense of awareness
among consumers for the safe purchase.
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